Amarin announces senior management changes
Connecticut firm appoints ceo, president and principal accountant
Zakrzewski has more than 20 years of experience, including holding the position of chief operating officer of Reliant Pharmaceuticals when Omacor/Lovaza was developed and acquired in 2007 by GlaxoSmithKline. He was most recently chief executive of Xcellerex, a Massachusetts-based biotechnology company. Although he currently serves on the boards of directors and in other advisory roles for various companies, Amarin is his primary business commitment.
Additionally, John Thero has been promoted to Amarin’s president. Since November 2009, he has been the company’s chief financial officer.
Prior to joining Amarin, Thero was chief financial officer at ViaCell, where he helped guide the sale of the company, and Abiomed, during its transition from a development-stage company into a commercial entity.
Colin Stewart, who was Amarin’s president and ceo, resigned last month to address personal matters.
In connection with these changes, Frederick Ahlholm, vice president finance, has become the company’s principal accounting officer.
You may also like
Pharmaceutical
Ardena strengthens executive team to drive its next phase of growth
Ghent, Belgium, 4 May 2026 – Ardena, a specialist pharmaceutical CDMO and bioanalytical CRO enabling precision medicines and other complex therapies, announces the appointments of Ben Ash as Chief Financial Officer and Henny Zijlstra as Chief Commercial Officer. These additions further strengthen Ardena’s executive leadership team as the company continues to scale its operations and commercial reach globally
Pharmaceutical
Backed by investments exceeding $1 billion, PCI Pharma Services announces major expansion of US sterile fill-finish and drug-device delivery combination capabilities
As pharma manufacturers prioritise US supply chain resilience, highlights include high-speed isolator filling lines for prefilled syringes, cartridges and vials, and drug-device combination assembly and packaging
Media
Romaco to debut Maximus 400 tablet coater with automatic baffle adjustment at Interpack
The Maximus 400 tablet coater is the first to automatically adjust baffle geometry as tablet bed volume increases, with an optional energy recovery system cutting consumption by up to 50%, alongside the VENTILUS Lab fluid bed processor, capable of reducing batch processing times by 25%
Manufacturing
SCIEX expands integrated software ecosystem with six mass spectrometry workflow collaborations
The firm has announced six software collaborations designed to unify instrument control, data processing and compliance within a single analytical environment, with more partnerships set to be revealed at ASMS 2026